Kura Oncology Inc (KURA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $8.65
• Market Cap: $744.87M
• EPS: $-2.48
• 52-Week High: $12.49
• 52-Week Low: $5.41

Market Sentiment

Kura Oncology Inc currently has a Neutral sentiment score of 0.11.

About Kura Oncology Inc

Kura Oncology, Inc. is a clinical-stage biopharmaceutical company headquartered in San Diego, focused on the discovery and development of innovative therapies for genetically defined tumors in oncology. With a robust pipeline of targeted treatment candidates, Kura aims to address significant unmet medical needs in cancer care. The company's dedication to rigorous clinical development, bolstered by strategic partnerships, positions it to deliver transformative therapeutic options and enhance p...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Kura Oncology Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does KURA pay dividends?

Kura Oncology Inc (KURA) does not currently pay a regular dividend.

What is KURA's market cap?

Kura Oncology Inc (KURA) has a market capitalization of $744.87M with a current stock price of $8.65.